COMMUNIQUÉS West-GlobeNewswire

Unum Therapeutics Announces Pricing of Initial Public Offering

29/03/2018 - 03:35

CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX ) (“Unum Therapeutics”), a clinical-stage biopharmaceutical company focused on the development of novel immunotherapy products [...]

Sorrento Therapeutics Chairman/CEO update to stockholders

29/03/2018 - 01:28

SAN DIEGO, March 28, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) Dear Sorrento Stockholders, Despite a recent short seller opinion piece aimed at undermining the credibility of Sorrento and its [...]

MediciNova Announces Collaboration with the University of Sydney Concord Cancer Centre to Evaluate MN-166 (ibudilast) in Chemotherapy-Induced Peripheral Neuropathy

29/03/2018 - 01:00

LA JOLLA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875 [...]

Mesoblast Phase 3 Cell Therapy Trial for Chronic Low Back Pain Completes Enrollment

29/03/2018 - 00:25

NEW YORK and MELBOURNE, Australia, March 28, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq: MESO ) today announced that enrollment has completed in the Phase 3 trial evaluating a single intra-discal [...]

Arbutus to Present HBV Data at 2018 EASL Liver Meeting

28/03/2018 - 23:54

VANCOUVER, British Columbia and WARMINSTER, Pa., March 28, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today [...]

Argos Therapeutics to Report Fourth Quarter and Year-End 2017 Financial Results and Operational Highlights on Monday, April 2, 2018

28/03/2018 - 23:00

DURHAM, N.C., March 28, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the [...]

Altimmune Announces Financial Results for the Year Ended December 31, 2017 and Provides Corporate Update

28/03/2018 - 22:44

Conference call and webcast scheduled for tomorrow, March 29 at 8:30am ET GAITHERSBURG, Md., March 28, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, today [...]

Sanofi: Availability of the Pre-quarterly Results Communication

28/03/2018 - 22:31

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Availability of the Pre-quarterly Results Communication Paris, France - March 28, 2018 - Sanofi announced today that its Pre-Quarterly Results Communication [...]

Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »

28/03/2018 - 22:31

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Mise en ligne du document «Pre-quarterly Results Communication » Paris, France - Le 28 mars 2018 - Sanofi annonce la mise en ligne sur l'espace [...]

Amarin to Present at the H.C. Wainwright Annual Global Life Sciences Conference

28/03/2018 - 22:30

BEDMINSTER, N.J. and DUBLIN, Ireland, March 28, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Molecular Templates, Inc. Reports Fourth Quarter 2017 Financial Results

28/03/2018 - 22:30

Update on MT-3724 Provided at World ADC Conference; More Data Expected in 2Q18 Upcoming Presentations at AACR Conference to Feature Data on PD-L1 Antigen Seeding ETB and HER2 ETB AUSTIN, Texas, March 28, 2018 (GLOBE [...]

Revive Therapeutics Retained Mi3 Communications for Investor Relations Services

28/03/2018 - 22:30

TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the “Company”) (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel [...]

HealthEquity Appoints New Director to the Board

28/03/2018 - 22:07

DRAPER, Utah, March 28, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the nation’s largest health savings account (HSA) non-bank custodian, today announced that its Board [...]

pSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex Woodlands Healthcare Partners – Company Will Rebrand as EyePoint Pharmaceuticals, Inc.

28/03/2018 - 22:05

Acquisition and additional funding significantly accelerate the company’s transformation to a specialty biopharmaceutical company with the potential to commercialize two ophthalmic products in 1H 2019 Icon Bioscience’s [...]

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

28/03/2018 - 22:05

BERKELEY HEIGHTS, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) ("Cyclacel" or the "Company") a biopharmaceutical company developing oral therapies that target [...]

Menlo Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

28/03/2018 - 22:05

REDWOOD CITY, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO ), a late-stage biopharmaceutical company focused on the development of serlopitant, for the treatment of pruritus [...]

Ascendis Pharma A/S Reports Full Year 2017 Financial Results

28/03/2018 - 22:01

- Rare Disease Endocrinology Pipeline Advances, with Significant Milestones Anticipated Over the Next Twelve Months - - Conference Call Today at 4:30 p.m. Eastern Time - COPENHAGEN, Denmark, March 28, 2018 (GLOBE [...]

Veloxis Announces the Publication of ASERTAA (A Study of Extended Release Tacrolimus in African-Americans), a Phase IIIb study of ENVARSUS XR®

28/03/2018 - 21:50

Investor News no. 01/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 28 March 2018 Veloxis Announces the Publication of ASERTAA (A Study of Extended Release Tacrolimus in African-Americans), a Phase IIIb study of [...]

Northeast Scientific Receives 510K Clearance on Reprocessed RF Stylet

28/03/2018 - 21:19

WATERBURY, Conn., March 28, 2018 (GLOBE NEWSWIRE) -- Northeast Scientific, Inc. (NES), known for its advanced medical device reprocessing capability, received another 510K clearance from the FDA on 27 March, this time [...]